drugset
drugset / Trial / NCT03285672

FP-101 for the Treatment of Hot Flashes in Postmenopausal Women

NCT03285672 ↗

Phase 2 Completed 109 enrolled Fervent Pharmaceuticals IQVIA Pty Ltd · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine the efficacy of FP-101 versus placebo for the treatment of hot flashes in postmenopausal women.

Timeline

Start
2018-03-26
Primary completion
2018-10-29
Completion
2018-10-29

Drugs

EvaluationDrugModalityDoseRoute
Subject FP-101 Unknown — —

Indications

No indication recorded.